Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Francisella tularensis Lipopolysaccharides (LPS) Monoclonal Antibody

Cat. No.VD7N149

Product TypeVeterinary Antibodies

Size 200 µg

Product Overview

BioVenic mouse monoclonal antibody is specific for Francisella tularensis lipopolysaccharides. It can be applied to ELISA and IF of Francisella tularensis lipopolysaccharides.

Specifications

Application ELISA; IF
Clonality Monoclonal
Classification Primary Antibody
Clone L13N44
Host Mouse
Target Species Bacteria
Species Reactivity Bacteria
Specificity Francisella tularensis Lipopolysaccharides
Isotype IgG3
Immunogen Inactivated Fr. tularensis pathogen
Purity > 90%
Conjugation Unconjugated
Preservative and Stabilizer 0.1% Sodium Azide
Physical State Liquid

Target Information

Francisella tularensis is a highly infectious bacterium that poses a significant threat to both humans and animals. Its lipopolysaccharides (LPS) are integral components of its outer membrane and play a crucial role in the bacterium's pathogenicity and immune evasion.NLPS is a major component of the bacterial cell wall and is involved in maintaining the structural integrity of the bacterium. In Francisella tularensis, it is implicated in immune modulation, allowing the bacterium to evade detection and clearance by the host's immune system

Target Francisella tularensis Lipopolysaccharides
Taxonomy ID 263

Shipping and Storage

This product is shipped with ice gel packs. Store at -20°C - -70°C(up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Soni, Shilpa, et al. "Francisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide O-antigen, core and lipid A and affects intramacrophage survival and vaccine efficacy." Frontiers in microbiology 1 (2010): 129.
Inquiry Basket